Aarti Surfactants Recommends ₹1 Dividend; Approves FY26 Financial Results
Aarti Surfactants Limited announced its audited financial results for the quarter and year ended March 31, 2026. The Board recommended a final dividend of ₹1 per equity share for FY26, subject to shareholder approval. The company also re-appointed its Cost and Internal Auditors for FY27 and reconstituted the Finance and Investment Committee.
The dividend announcement is a direct positive for shareholders. The approval of financial results is routine but important. Re-appointment of auditors and committee reconstitution are standard corporate actions.
The recommendation of a dividend and the approval of financial results are positive developments for shareholders.
Aarti Surfactants Limited announced the outcome of its Board Meeting held on Saturday, May 09, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. These results include the Statement of Assets and Liabilities and the Cash Flow Statement, along with the auditor's report, which was unmodified.
The company also recommended a final dividend of ₹1 per equity share (10% of face value of ₹10) for the financial year ended March 31, 2026. This recommendation is subject to shareholder approval at the upcoming Annual General Meeting.
Furthermore, the Board approved the re-appointment of PHS & Associates as the Cost Auditor and Raman S. Shah & Co. as the Internal Auditor for the financial year 2026-2027. The Finance and Investment Committee of the Board has been reconstituted with the inclusion of Mr. Parimal H. Desai, effective May 09, 2026.
The Board Meeting commenced at 11:40 a.m. and concluded at 02:00 p.m. The financial results are available on the company's website.
What to do with a filing like this
Aarti Surfactants Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aarti Surfactants Limited. Read the original for the full detail.